Skip to main content
. 1999 Nov;43(11):2579–2585. doi: 10.1128/aac.43.11.2579

TABLE 2.

Fluoroquinolone susceptibilities of S. pneumoniae C3LN4, first-step mutants, and clinical isolates

Strain Fluoroquinolone MIC (μg/ml)a
LVFX OFLX CPFX SPFX STFX
C3LN4 0.1 0.3 0.2 0.15 0.005
SPFX1b 0.1 0.3 0.2 0.4 0.005
CPFX1c 0.1 0.3 0.5 0.15 0.005
OFLX1d 0.3 0.75 0.6 0.8 0.005
JP17e 6.25 12.5 6.25 1.56 0.39
JP27e 25 50 50 25 0.39
a

LVFX, levofloxacin; OFLX, ofloxacin; CPFX, ciprofloxacin; SPFX, sparfloxacin; STFX, sitafloxacin. Those MICs greater than those for the wild type are shown in boldface type. 

b

Selected with sparfloxacin (the MICs for the other five mutants were identical). 

c

Selected with ciprofloxacin (MICs for the other 11 mutants were identical). 

d

Selected with ofloxacin. 

e

Clinical isolates.